Related by context. Frequent words. (Click for all words.) 80 myocardial infarction stroke 73 cardiovascular hospitalization 72 myocardial infarction MI 67 cardiovascular mortality 66 confidence interval #.#-#.# 66 composite endpoint 65 thromboembolic events 65 thrombotic events 65 myocardial infarctions 64 coronary revascularization 64 thromboembolism 64 cardiovascular morbidity 63 left ventricular dysfunction 63 myocardial infarction 62 confidence interval CI 62 stroke myocardial infarction 62 nonsignificant 62 % CI #.#-#.# [006] 61 laboratory abnormalities 61 acute coronary 61 hyperkalemia 60 discontinuations due 60 cardiogenic shock 60 nonfatal heart 60 target vessel revascularization 60 treatment emergent adverse 60 % CI #.#-#.# [002] 60 pulmonary embolism PE 60 recurrent stroke 59 unfractionated heparin 59 renal dysfunction 59 vertebral fracture 59 cardiac dysfunction 59 renal insufficiency 59 candesartan 58 HbA1c levels 58 rehospitalization 58 cardiovascular disease CVD 58 left ventricular hypertrophy 58 enalapril 58 unstable angina 58 cerebrovascular 58 LVEF 58 intracerebral hemorrhage 58 cerebrovascular disease 58 VTE 58 P = .# 58 acute coronary syndrome 58 Coronary heart 58 acute myocardial infarction AMI 58 severe renal impairment 58 ST elevation myocardial 58 venous thrombosis 57 coronary heart 57 ischemic stroke 57 annualized relapse 57 postoperative complications 57 spinal cord compression 57 stable angina 57 severe hypoglycemia 57 Arch Intern Med 57 Coronary artery disease 57 hepatotoxicity 57 myocardial ischemia 57 venous thromboembolism 57 Secondary endpoints include 57 valsartan 57 target lesion revascularization 56 hepatic impairment 56 proteinuria 56 Secondary endpoints included 56 events SAEs 56 QT prolongation 56 microalbuminuria 56 QTc 56 elevated triglycerides 56 hypercalcemia 56 infarct size 56 angina pectoris 56 endarterectomy 56 ischemic strokes 56 hypokalemia 56 density lipoprotein cholesterol 56 lipid lowering drugs 56 coronary artery disease 56 cardiovascular disease 56 pioglitazone 56 nonadherence 56 patients receiving ERBITUX 56 fasting insulin 56 acute myocardial infarction 55 tumor recurrence 55 hsCRP 55 enoxaparin 55 perindopril 55 virologic failure 55 bronchospasm 55 MIs 55 glimepiride 55 NYHA class 55 hypomagnesemia